Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is FOSAPREPITANT DIMEGLUMINE, with a corresponding US DMF Number 31470.
Remarkably, this DMF maintains an Active status since its submission on March 16, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 17, 2017, and payment made on March 15, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II